Cargando…

Cardiac-Specific IGF-1 Receptor Transgenic Expression Protects Against Cardiac Fibrosis and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy

OBJECTIVE: Compelling epidemiological and clinical evidence has identified a specific cardiomyopathy in diabetes, characterized by early diastolic dysfunction and adverse structural remodeling. Activation of the insulin-like growth factor 1 (IGF-1) receptor (IGF-1R) promotes physiological cardiac gr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huynh, Karina, McMullen, Julie R., Julius, Tracey L., Tan, Joon Win, Love, Jane E., Cemerlang, Nelly, Kiriazis, Helen, Du, Xiao-Jun, Ritchie, Rebecca H.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874713/ https://www.ncbi.nlm.nih.gov/pubmed/20215428 http://dx.doi.org/10.2337/db09-1456

Ejemplares similares

Long-Term Overexpression of Hsp70 Does Not Protect against Cardiac Dysfunction and Adverse Remodeling in a MURC Transgenic Mouse Model with Chronic Heart Failure and Atrial Fibrillation
por: Bernardo, Bianca C., et al.
Publicado: (2015)

In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function
por: Bernardo, Bianca C., et al.
Publicado: (2022)

CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy
por: Chu, Po-Yin, et al.
Publicado: (2019)

N-Acetylcysteine Attenuates the Development of Renal Fibrosis in Transgenic Mice with Dilated Cardiomyopathy
por: Giam, Beverly, et al.
Publicado: (2017)

Silencing of miR-34a Attenuates Cardiac Dysfunction in a Setting of Moderate, but Not Severe, Hypertrophic Cardiomyopathy
por: Bernardo, Bianca C., et al.
Publicado: (2014)

IGF1–PI3K-induced physiological cardiac hypertrophy: Implications for new heart failure therapies, biomarkers, and predicting cardiotoxicity
por: Bass-Stringer, Sebastian, et al.
Publicado: (2021)

Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload
por: Bernardo, Bianca C., et al.
Publicado: (2016)

Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy
por: Chacko, Binita Riya, et al.
Publicado: (2018)

Troponin Mutation Caused Diastolic Dysfunction and Experimental Treatment in Transgenic Mice with Cardiomyopathy
por: Xu, Yang, et al.
Publicado: (2015)

ATTR Cardiomyopathy Meets Multiple Myeloma: The Importance of Cardiac Biopsy
por: Kanelidis, Anthony J., et al.
Publicado: (2021)

Diminazene Aceturate Improves Cardiac Fibrosis and Diastolic Dysfunction in Rats with Kidney Disease
por: Velkoska, Elena, et al.
Publicado: (2016)

Diastolic dysfunction in a pre-clinical model of diabetes is associated with changes in the cardiac non-myocyte cellular composition
por: Cohen, Charles D., et al.
Publicado: (2021)

Synergistic cardiac pathological hypertrophy induced by high-salt diet in IGF-IIRα cardiac-specific transgenic rats
por: Chang, Ruey-Lin, et al.
Publicado: (2019)

Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling
por: Lee, Seul-Gee, et al.
Publicado: (2022)

Green tea extract catechin improves cardiac function in pediatric cardiomyopathy patients with diastolic dysfunction
por: Quan, Junjun, et al.
Publicado: (2019)

Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction
por: Schimmel, Katharina, et al.
Publicado: (2020)

Identification of target genes in cardiomyopathy with fibrosis and cardiac remodeling
por: Zhao, Jianquan, et al.
Publicado: (2018)

Mapping the cellular and molecular landscape of cardiac non-myocytes in murine diabetic cardiomyopathy
por: Cohen, Charles D., et al.
Publicado: (2023)

Overexpression of Heat Shock Protein 70 Improves Cardiac Remodeling and Survival in Protein Phosphatase 2A-Expressing Transgenic Mice with Chronic Heart Failure
por: Yoon, Somy, et al.
Publicado: (2021)

Cardiac macrophages promote diastolic dysfunction
por: Hulsmans, Maarten, et al.
Publicado: (2018)

Assessment of diastolic function from velocity-encoded cardiac magnetic resonance data in patients with hypertrophic cardiomyopathy
por: Ashrafpoor, Golmehr, et al.
Publicado: (2013)

Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy
por: Cheng, Yanan, et al.
Publicado: (2023)

Bone Morphogenetic Protein 7 Gene Delivery Improves Cardiac Structure and Function in a Murine Model of Diabetic Cardiomyopathy
por: Tate, Mitchel, et al.
Publicado: (2021)

Arrhythmogenic Hearts in PKD2 Mutant Mice Are Characterized by Cardiac Fibrosis, Systolic, and Diastolic Dysfunctions
por: Amirrad, Farideh, et al.
Publicado: (2021)

Abnormal diastolic function underlies the different beneficial effects of cardiac resynchronization therapy on ischemic and non-ischemic cardiomyopathy
por: Wang, Qi, et al.
Publicado: (2017)

Characterization of Aging-Associated Cardiac Diastolic Dysfunction
por: Chang, Wei-Ting, et al.
Publicado: (2014)

Exercise cardiac MR assessment of diastolic function
por: Francois, Christopher J, et al.
Publicado: (2015)

Cardiac inflammation and diastolic dysfunction in hypercholesterolemic rabbits
por: Nachar, Walid, et al.
Publicado: (2019)

Adiponectin – stratification biomarker in diastolic cardiac dysfunction
por: Dincă, Valeriu-Gabi, et al.
Publicado: (2023)

Evaluation of diastolic dysfunction in children with hypertrophic cardiomyopathy and its relationship with development of myocardial fibrosis
por: Deraz, Salem Elsayed, et al.
Publicado: (2023)

The Impact of Trimetazidine on Cardiac Fibrosis, Inflammation, and Function in Ischemic Cardiomyopathy Patients
por: El-khodary, Noha M., et al.
Publicado: (2022)

A novel cardiac magnetic resonance imaging technique to evaluate left ventricular diastolic function in patients with hypertrophic cardiomyopathy
por: Saba, Shahryar G, et al.
Publicado: (2012)

Correlation between changes in diastolic dysfunction and health-related quality of life after cardiac rehabilitation program in dilated cardiomyopathy
por: Mehani, Sherin H.M.
Publicado: (2013)

Skeletal Myoblast Cell Sheet Implantation Ameliorates Both Systolic and Diastolic Cardiac Performance in Canine Dilated Cardiomyopathy Model
por: Shirasaka, Tomonori, et al.
Publicado: (2016)

Diastolic dysfunction assessed by cardiac magnetic resonance imaging tissue tracking on normal-thickness wall segments in hypertrophic cardiomyopathy
por: Qiao, Jinhan, et al.
Publicado: (2023)

IGF-1 protects against angiotensin II-induced cardiac fibrosis by targeting αSMA
por: Ock, Sangmi, et al.
Publicado: (2021)

Comparison of cardiac DTI parameters between systole and diastole
por: McGill, Laura-Ann, et al.
Publicado: (2014)

Pericardial fat and its influence on cardiac diastolic function
por: de Wit-Verheggen, Vera H. W., et al.
Publicado: (2020)

Cardiac Remodeling and Diastolic Dysfunction in Paroxysmal Atrial Fibrillation
por: Noirclerc, Nathalie, et al.
Publicado: (2021)

Comparison of regional and global cardiac MRI diastolic strain rates with echo grading of diastolic dysfunction
por: Pandey, Tarun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_df191pad2i2tpvk3tga5e322p9